共 224 条
[1]
Ott JJ(2012)Global epidemiology of hepatitis B virus infection: new estimates of age–specific HBsAg seroprevalence and endemicity Vaccine 30 2212-2219
[2]
Stevens GA(2004)Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 97-107
[3]
Groeger J(2009)Management of hepatitis B in China Chin Med J 122 3-4
[4]
Wiersma ST(2012)Asian–Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 531-561
[5]
Lavanchy D(2015)Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma World J Hepatol 7 1742-1010
[6]
Lu FM(2013)Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency Clin Gastroenterol Hepatol 11 1004-1332
[7]
Zhuang H(2014)HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability Gut 63 1325-1887
[8]
Liaw Y(2013)Relapse of chronic hepatitis B after discontinuation of nucleos(t)ide analogs: Is the glass half full or half empty Hepatology 58 1885-130
[9]
Kao J(2011)The clinical implications of hepatitis B virus genotype: recent advances J Gastroenterol Hepatol 26 123-1002
[10]
Piratvisuth T(2000)Hepatitis B genotypes and the response to interferon therapy J Hepatol 33 998-1430